Hypoxia-induced angiogenesis is increased by the controlled release of deferoxiamine from gelatin hydrogels

Acta Biomaterialia

Volumn 10, Issue 8, 2014, Pages 3641-3649

  Saito, Takashi ^a   Tabata, Yasuhiko ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Controlled release; Deferoxiamine; Gelatin hydrogel; Hypoxia

Indexed keywords

BIOACTIVITY; BLOOD VESSELS; ENDOTHELIAL CELLS; GENE EXPRESSION; INDIUM COMPOUNDS; SOLUTIONS;

ANGIOGENESIS; BIODEGRADABLE HYDROGELS; CONTROLLED RELEASE; DEFEROXIAMINE; GELATIN HYDROGELS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HYPOXIA; HYPOXIA-INDUCIBLE FACTORS; PHOSPHATE BUFFERED SALINE SOLUTIONS; VASCULAR ENDOTHELIAL GROWTH FACTOR;

HYDROGELS;

COLLAGENASE; DEFEROXAMINE; GELATIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PHOSPHATE BUFFERED SALINE; PLATELET DERIVED GROWTH FACTOR B; VASCULOTROPIN; DELAYED RELEASE FORMULATION; HYDROGEL; SIDEROPHORE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; AQUEOUS SOLUTION; ARTICLE; BIOLOGICAL ACTIVITY; BLOOD VESSEL; CELL COUNT; CELL VIABILITY; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CYTOTOXICITY; DEGRADATION; GENE EXPRESSION; HUMAN; HUMAN CELL; HYDROGEL; HYPOXIA; LIMB ISCHEMIA; MALE; MOUSE; NONHUMAN; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TEMPERATURE; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR SMOOTH MUSCLE; ADMINISTRATION AND DOSAGE; ANIMAL; BAGG ALBINO MOUSE; CELL CULTURE; CELL HYPOXIA; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG EFFECTS; ENDOTHELIUM CELL; ISCHEMIA; LEG; PATHOLOGY; PHYSIOLOGY; TREATMENT OUTCOME; VASCULARIZATION;

ANIMALS; CELL HYPOXIA; CELLS, CULTURED; DEFEROXAMINE; DELAYED-ACTION PREPARATIONS; ENDOTHELIAL CELLS; GELATIN; HUMANS; HYDROGELS; ISCHEMIA; LEG; MALE; MICE; MICE, INBRED BALB C; NEOVASCULARIZATION, PHYSIOLOGIC; SIDEROPHORES; TREATMENT OUTCOME;

EID: 84903740299     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2014.04.021     Document Type: Article

References (50)

1. A. Carreau, B. El Hafny-Rahbi, A. Matejuk, C. Grillon, and C. Kieda Why is the partial oxygen pressure of human tissues a crucial parameter? Small molecules and hypoxia J Cell Mol Med 15 2011 1239 1253
2. M. Korsic, D. Jugovic, and B. Kremzar Intracranial pressure and biochemical indicators of brain damage: follow-up study Croat Med J 47 2006 246 252
3. Q.T. Le, E. Chen, A. Salim, H. Cao, C.S. Kong, and R. Whyte et al. An evaluation of tumor oxygenation and gene expression in patients with early stage non-small cell lung cancers Clin Cancer Res 12 2006 1507 1514
4. A.J. Brooks, J.S. Hammond, K. Girling, and I.J. Beckingham The effect of hepatic vascular inflow occlusion on liver tissue pH, carbon dioxide, and oxygen partial pressures: defining the optimal clamp/release regime for intermittent portal clamping J Surg Res 141 2007 247 251
5. M. Muller, W. Padberg, E. Schindler, J. Sticher, C. Osmer, and S. Friemann et al. Renocortical tissue oxygen pressure measurements in patients undergoing living donor kidney transplantation Anesth Analg 87 1998 474 476
6. R.S. Richardson, S. Duteil, C. Wary, D.W. Wray, J. Hoff, and P.G. Carlier Human skeletal muscle intracellular oxygenation: the impact of ambient oxygen availability J Physiol 571 2006 415 424
7. J.S. Harrison, P. Rameshwar, V. Chang, and P. Bandari Oxygen saturation in the bone marrow of healthy volunteers Blood 99 2002 394
8. 2 availability on human cancer Nat Rev Cancer 8 2008 967 975
9. J.S. Lewis, J.A. Lee, J.C. Underwood, A.L. Harris, and C.E. Lewis Macrophage responses to hypoxia: relevance to disease mechanisms J Leukoc Biol 66 1999 889 900
10. J.E. Shay, and M. Celeste Simon Hypoxia-inducible factors: crosstalk between inflammation and metabolism Semin Cell Dev Biol 23 2012 389 394
11. Y.Z. Gu, S.M. Moran, J.B. Hogenesch, L. Wartman, and C.A. Bradfield Molecular characterization and chromosomal localization of a third alpha-class hypoxia inducible factor subunit, HIF3alpha Gene Expr 7 1998 205 213
12. G.L. Wang, and G.L. Semenza Purification and characterization of hypoxia-inducible factor 1 J Biol Chem 270 1995 1230 1237
13. G.L. Semenza Hypoxia-inducible factors in physiology and medicine Cell 148 2012 399 408
14. J.D. Firth, B.L. Ebert, C.W. Pugh, and P.J. Ratcliffe Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: similarities with the erythropoietin 3′ enhancer Proc Natl Acad Sci USA 91 1994 6496 6500
15. G.L. Semenza, P.H. Roth, H.M. Fang, and G.L. Wang Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1 J Biol Chem 269 1994 23757 23763
16. B.L. Ebert, J.D. Firth, and P.J. Ratcliffe Hypoxia and mitochondrial inhibitors regulate expression of glucose transporter-1 via distinct Cis-acting sequences J Biol Chem 270 1995 29083 29089
17. A.P. Levy, N.S. Levy, S. Wegner, and M.A. Goldberg Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia J Biol Chem 270 1995 13333 13340
18. J.W. Jeong, M.K. Bae, M.Y. Ahn, S.H. Kim, T.K. Sohn, and M.H. Bae et al. Regulation and destabilization of HIF-1alpha by ARD1-mediated acetylation Cell 111 2002 709 720
19. D.J. Manalo, A. Rowan, T. Lavoie, L. Natarajan, B.D. Kelly, and S.Q. Ye et al. Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1 Blood 105 2005 659 669
20. A. Zagorska, and J. Dulak HIF-1: the known's and unknowns of hypoxia sensing Acta Biochim Pol 51 2004 563 585
21. L.E. Huang, Z. Arany, D.M. Livingston, and H.F. Bunn Activation of hypoxia-inducible transcription factor depends primarily upon redox-sensitive stabilization of its alpha subunit J Biol Chem 271 1996 32253 32259
22. C. Brahimi-Horn, N. Mazure, and J. Pouyssegur Signalling via the hypoxia-inducible factor-1alpha requires multiple posttranslational modifications Cell Signal 17 2005 1 9
23. U. Berchner-Pfannschmidt, S. Tug, M. Kirsch, and J. Fandrey Oxygen-sensing under the influence of nitric oxide Cell Signal 22 2010 349 356
24. J.M. Gleadle, B.L. Ebert, J.D. Firth, and P.J. Ratcliffe Regulation of angiogenic growth factor expression by hypoxia, transition metals, and chelating agents Am J Physiol 268 1995 C1362 C1368
25. C.J. Schofield, and P.J. Ratcliffe Oxygen sensing by HIF hydroxylases Nat Rev Mol Cell Biol 5 2004 343 354
26. G.L. Wang, and G.L. Semenza Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction Blood 82 1993 3610 3615
27. Y. Ikeda, S. Tajima, S. Yoshida, N. Yamano, Y. Kihira, and K. Ishizawa et al. Deferoxamine promotes angiogenesis via the activation of vascular endothelial cell function Atherosclerosis 215 2011 339 347
28. H. Thangarajah, D. Yao, E.I. Chang, Y. Shi, L. Jazayeri, and I.N. Vial et al. The molecular basis for impaired hypoxia-induced VEGF expression in diabetic tissues Proc Natl Acad Sci USA 106 2009 13505 13510
29. P.E. Hallaway, J.W. Eaton, S.S. Panter, and B.E. Hedlund Modulation of deferoxamine toxicity and clearance by covalent attachment to biocompatible polymers Proc Natl Acad Sci USA 86 1989 10108 10112
30. Y. Tabata, A. Nagano, and Y. Ikada Biodegradation of hydrogel carrier incorporating fibroblast growth factor Tissue Eng 5 1999 127 138
31. T. Kushibiki, R. Tomoshige, K. Iwanaga, M. Kakemi, and Y. Tabata Controlled release of plasmid DNA from hydrogels prepared from gelatin cationized by different amine compounds J Controlled Release 112 2006 249 256
32. G. Matsumoto, T. Kushibiki, Y. Kinoshita, U. Lee, Y. Omi, and E. Kubota et al. Cationized gelatin delivery of a plasmid DNA expressing small interference RNA for VEGF inhibits murine squamous cell carcinoma Cancer Sci 97 2006 313 321
33. X. Guo, J. Liao, H. Park, A. Saraf, R.M. Raphael, and Y. Tabata et al. Effects of TGF-beta3 and preculture period of osteogenic cells on the chondrogenic differentiation of rabbit marrow mesenchymal stem cells encapsulated in a bilayered hydrogel composite Acta Biomater 6 2010 2920 2931
34. M. Matsui, and Y. Tabata Enhanced angiogenesis by multiple release of platelet-rich plasma contents and basic fibroblast growth factor from gelatin hydrogels Acta Biomater 8 2012 1792 1801
35. Y. Tabata Tissue regeneration based on growth factor release Tissue Eng 9 Suppl. 1 2003 S5 S15
36. H. Wang, O.C. Boerman, K. Sariibrahimoglu, Y. Li, J.A. Jansen, and S.C. Leeuwenburgh Comparison of micro- vs. nanostructured colloidal gelatin gels for sustained delivery of osteogenic proteins: bone morphogenetic protein-2 and alkaline phosphatase Biomaterials 33 2012 8695 8703
37. T. Saito, and Y. Tabata Preparation of gelatin hydrogels incorporating low-molecular-weight heparin for anti-fibrotic therapy Acta Biomater 8 2012 646 652
38. T. Tanigo, R. Takaoka, and Y. Tabata Sustained release of water-insoluble simvastatin from biodegradable hydrogel augments bone regeneration J Controlled Release 143 2010 201 206
39. M. Konishi, Y. Tabata, M. Kariya, A. Suzuki, M. Mandai, and K. Nanbu et al. In vivo anti-tumor effect through the controlled release of cisplatin from biodegradable gelatin hydrogel J Controlled Release 92 2003 301 313
40. D. Sivakumaran, D. Maitland, and T. Hoare Injectable microgel-hydrogel composites for prolonged small-molecule drug delivery Biomacromolecules 12 2011 4112 4120
41. J.P. Chen, Y.L. Leu, C.L. Fang, C.H. Chen, and J.Y. Fang Thermosensitive hydrogels composed of hyaluronic acid and gelatin as carriers for the intravesical administration of cisplatin J Pharm Sci 100 2011 655 666
42. S. Gordon, E. Teichmann, K. Young, K. Finnie, T. Rades, and S. Hook In vitro and in vivo investigation of thermosensitive chitosan hydrogels containing silica nanoparticles for vaccine delivery Eur J Pharm Sci 41 2010 360 368
43. L. Indolfi, F. Causa, C. Giovino, F. Ungaro, F. Quaglia, and P.A. Netti Microsphere-integrated drug-eluting stents: PLGA microsphere integration in hydrogel coating for local and prolonged delivery of hydrophilic antirestenosis agents J Biomed Mater Res Part A 97 2011 201 211
44. M.C. Chen, H.W. Tsai, C.T. Liu, S.F. Peng, W.Y. Lai, and S.J. Chen et al. A nanoscale drug-entrapment strategy for hydrogel-based systems for the delivery of poorly soluble drugs Biomaterials 30 2009 2102 2111
45. R.S. Navath, A.R. Menjoge, H. Dai, R. Romero, S. Kannan, and R.M. Kannan Injectable PAMAM dendrimer-PEG hydrogels for the treatment of genital infections: formulation and in vitro and in vivo evaluation Mol Pharm 8 2011 1209 1223
46. R.J. Ward, D. Dexter, A. Florence, F. Aouad, R. Hider, and P. Jenner et al. Brain iron in the ferrocene-loaded rat: its chelation and influence on dopamine metabolism Biochem Pharmacol 49 1995 1821 1826
47. M. Tanaka, A. Sotomatsu, H. Kanai, and S. Hirai Dopa and dopamine cause cultured neuronal death in the presence of iron J Neurol Sci 101 1991 198 203
48. T. Lofstedt, E. Fredlund, L. Holmquist-Mengelbier, A. Pietras, M. Ovenberger, and L. Poellinger et al. Hypoxia inducible factor-2alpha in cancer Cell Cycle 6 2007 919 926
49. S.B. Catrina, K. Okamoto, T. Pereira, K. Brismar, and L. Poellinger Hyperglycemia regulates hypoxia-inducible factor-1alpha protein stability and function Diabetes 53 2004 3226 3232
50. W. Xue, L. Cai, Y. Tan, P. Thistlethwaite, Y.J. Kang, and X. Li et al. Cardiac-specific overexpression of HIF-1{alpha} prevents deterioration of glycolytic pathway and cardiac remodeling in streptozotocin-induced diabetic mice Am J Pathol 177 2010 97 105